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Azole-resistant Aspergillus 
fumigatus harboring TR34/L98H, 
TR46/Y121F/T289A and TR53 
mutations related to flower  
fields in Colombia
Carlos Alvarez-Moreno1,2,3, Rose-Anne Lavergne3,4,  Ferry Hagen5, Florent Morio3,4, 
Jacques F. Meis5,6 & Patrice Le Pape3,4
Resistance to triazoles in Aspergillus fumigatus has been reported in azole-naive patients in Europe, 
Asia, Australia and North America. This resistance has been linked to fungicide-driven mutations in the 
cyp51A gene and its promoter region. We investigated the presence of environmental azole-resistant 
A. fumigatus strains related to the use of azole fungicides in Colombia. Soil samples were collected from 
flower beds, flower fields and public gardens from the outskirts, suburbs and city centre of Bogotá. Out 
of the 86 soil samples taken, 17 (19.8%) grew A. fumigatus of whom eight (9.3%) contained 40 strains 
able to grow on azole-containing itraconazole and/or voriconazole supplemented media. All but one 
triazole-resistant strains were isolated from soil samples collected from flower fields and flower beds 
(39/40). Importantly, the majority had the TR46/Y121F/T289A, TR34/L98H, and TR53 molecular resistance 
mechanisms and one azole resistant strain had a wild-type cyp51A gene. Soil samples from flower fields 
and beds contained 4 azole fungicides (penconazole, difenoconazole, tetraconazole and tebuconazole) 
above the limit of detection. Our findings underline the need for extensive investigations to determine 
azole-resistant A. fumigatus prevalence in both clinical and environmental samples in other regions of 
Latin America.
Triazole-resistant Aspergillus fumigatus is increasingly reported in Europe since the late 2000s. This emerging 
public health concern occurs through two distinct pathways: in vivo selection of resistance as a consequence of 
long-term treatment with medical azoles or de novo acquisition of a resistant strain directly from the environ-
ment, linked to the widespread use of azole fungicides in agriculture. This second route of resistance acquisition 
was initially described in The Netherlands and then reported in several countries in Europe, Asia and Africa1–3 
explaining the recent emergence of resistant A. fumigatus in azole-naive patients. In Europe, a relationship was 
found between environmental azole use and development of cross-resistance to medical triazoles through TR34/
L98H and TR46/Y121F/T289A mutations in the cyp51A gene and its promoter region4. Recently, both the TR34/
L98H and TR46/Y121F/T289A mutations were reported in A. fumigatus strains collected from several institutions 
throughout the United States5,6.
A large number of demethylation inhibitor (DMI) fungicides have been used intensively in agriculture since 
the 1970s7. More than thirty molecules are registered for each application field, but only a few are intrinsically 
active against A. fumigatus7,8. According to the Food and Agriculture Organization of the United Nations, 
Colombia was the fourth largest consumer of pesticides in arable lands and permanent crops in 2010 (14.5 tons 
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per 1000 ha)9. Also, according to the pesticide report of the Ministry of Agriculture and Integrated Rural 
Development of Colombia for the period 2006–2013, fungicides ranked second in sales after herbicides (43 and 
34%, respectively)10. Fungicides are authorized for use in a large variety of agricultural applications including 
flower production11.
Given this possible association between the use of DMI in agriculture and the emergence of azole-resistant 
A. fumigatus3,4,12,13 and the fact that Colombia is a country with a high flower production (second producer 
worldwide), we recently evaluated the presence of environmental resistance to azoles of medical importance in A. 
fumigatus isolated from flower fields and described the first environmental azole-resistant A. fumigatus strains in 
South America14. To gain further insights into this potential public health issue, we decided to conduct a comple-
mentary study by extending the sampling and to explore the genetic relationship between strains found in flower 
fields, ornamental plant beds and urban public gardens. In addition, concentrations of triazole fungicides used 
in Colombian floriculture were measured in the same soil samples. Finally, antifungal activity of flutriafol against 
wild-type A. fumigatus was also investigated.
Results
After analysis of the fungicides applied in Colombia, as well as their use in agriculture, the horticulture sector was 
selected because of its great number of combined or single fungicide molecules approved (about thirty distinct 
compounds in 2015). Soil samples (n = 86) from nine different flower fields (n = 32) and flower beds (n = 12) 
in the outskirts of Bogotá and public gardens (n = 42) of the city centre were collected (Fig. 1). From the 86 soil 
samples, 17 (19.8%) were positive for A. fumigatus on Sabouraud Dextrose Agar plates among of which 8 exhib-
ited strains able to grow on supplemented agar with itraconazole or voriconazole (n = 40 single colonies). Most 
triazole-resistant strains were detected in soil samples from flower fields and flower beds (n = 39/40) whereas only 
one strain was isolated from one of the inner city soil samples (Fig. 1). Of the 40 azole-resistant Aspergillus section 
Fumigati strains, 21 (up to 5 colonies for each positive culture) were identified as A. fumigatus by sequencing of 
the β -tubulin gene and further selected to analyze resistance mechanisms. Results showed a great diversity in 
molecular resistance mechanism with a larger number of strains harbouring TR46/Y121F/T289A (n = 17; 80.9%) 
followed by TR53 (n = 2) and TR34/L98H (n = 1) and finally one azole resistant strain was cyp51A wild-type. All 
A. fumigatus strains harbouring the TR46/Y121F/T289A mutation grew on voriconazole and itraconazole plates 
whereas TR53, TR34/L98H and the cyp51A wild-type strains grew only on itraconazole-containing agar plates.
Figure 1. Localization of samplings: (A) outskirts, suburbs (flower fields and green houses, red triangles), 
which were positive to azole resistant Aspergillus fumigatus. (B) West, North and downtown areas of the city of 
Bogotá (public gardens, yellow triangles), which were negative, except National Park (red asterisk). Map data: 
Google GeoBasis-DE/BKG and Google, INEGI.
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Strikingly, microsatellite genotyping of the azole-resistant strains from Colombia highlighted a large geno-
typic diversity, not only among strains with different molecular resistance mechanisms (cyp51A wild type, TR34/
L98H and TR53) but also in those with TR46/Y121F/T289A (Fig. 2). The Colombian TR46/Y121F/T289A strains 
were genetically unrelated to Dutch TR46/Y121F/T289A clinical and environmental strains as was the single 
Colombian TR34/L98H strain. Notably, some isolates taken in flower fields were genetically undistinguishable 
from others collected in flower beds in the outskirts of Bogotá, located a few kilometres apart. The rarely occur-
ring TR53 resistance mechanism was found in only two strains (flower field soil and public garden soil) in the 
city centre. Genotyping showed these strains to be different from each other and from the single, previously 
published, Dutch strain.
Azole fungicides currently approved for use in Colombia in floriculture and azole antifungal drugs with activ-
ity against aspergilli were reported according to the date of registration for floriculture (Fig. 3). Because of the 
lack of data on antifungal activity of flutriafol against A. fumigatus, this DMI and tebuconazole (comparator) 
MICs were evaluated against 16 wild-type strains. Flutriafol had no activity against any of the A. fumigatus tested 
(MICs > 8 mg/L) while tebuconazole MICs ranged from 2 to 8 mg/L.
Finally, azole fungicides were measured in two representative pooled soil samples with LC-MS/MS. The results 
showed that in the soil of flower crops, the presence of penconazole (0.15 mg/kg), difenoconazole (0.41 mg/kg), 
tetraconazole (0.49 mg/kg) and tebuconazole (0.69 mg/kg) were found while the public garden soils had no 
detectable presence of any fungicide.
Figure 2. Genotypic relationship of A. fumigatus strains from environmental samples collected from 
the surroundings of a outskirts, suburbs and downtown areas of the city of Bogotá, Colombia (including 
TR46/Y121F/T289A, n = 17; TR34/L98H, n = 1;TR53, n = 2 and wild-type, n = 1) with resistant strains from 
the Netherlands (TR46/Y121F/T289A, 5 clinical and 1 environmental strains; TR34/L98H, 9 clinical and 5 
environmental strains and one TR53 clinical strain). The dendrogram is based on a categorical analysis of nine 
microsatellite markers in combination with UPGMA clustering.
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Discussion
Fungal plant diseases cause extensive losses of crops in every area of human agriculture. Currently close to 150 
different fungicidal compounds, formulated and sold in a several fold larger number of different proprietary 
products, are used worldwide in agriculture8,12. In Colombia, many fungicides are currently licensed for crop 
treatment with a number of chemical groups available in floriculture such as acylanines, methocy-acylates, car-
boxamides, carbamates, phthalimides, imidazoles, triazoles, to be used against Botrytis cinerea (chrysanthemum, 
carnation and rose crops), Cladosporium echinolatum and Uromyces dianthi (Carnation), Sphaerotheca pannesa, 
Phramidium mucronatum (rose), Puccinia chrysanthemi (chrysanthemum), among others. Triazole fungicide 
consumption remains high in Colombia, although there is a decrease in recent years. In the year 2000 fungicides 
accounted for 36% of total pesticide sales, of which 80% were triazoles. During the period 2006–2013, fungicides 
constituted 34% of pesticide sales with 23.7 and 36% in amount of number of litres and tons, respectively10. It is 
emphasized that triazoles such as bromuconazole, difenoconazole, epoxiconazole, propiconazole and tebucona-
zole in 2003 were 20% of total consumption of fungicides in Colombia compared to 15.8% in 2013 (7.2 and 8.6% 
as simple or combined products)10,11,15. Interestingly among the eight triazoles registered for use in floriculture in 
Colombia, flutriafol (this study), cyproconazole, penconazole and triadimefon have no activity against A. fumig-
atus and of the four compounds remaining, only hexaconazole has limited activity. The remaining three (difeno-
conazole, tebuconazole, epoxiconazole) with chemical similarity to the medical triazoles exhibited high activity 
against A. fumigatus. They have already been listed as possible candidates to induce resistance in Aspergillus, espe-
cially tebuconazole4,16,17. The soil samples analysis showed the presence of 3 triazole fungicides (tebuconazole, 
difenoconazole and tetraconazole). It is noteworthy that the latter is not registered for use in the flower industry11. 
Although in vitro induction of alterations in the promoter region following in vitro exposure to DMIs was not 
successful4, the fact that we found azole-resistant A. fumigatus in the same soil samples increases suspicion of an 
association among these fungicides and the spread of Aspergillus resistance in floriculture.
Notably, our study on azole resistance in A. fumigatus showed a great diversity of resistance mechanisms 
with a predominance of TR46/Y121F/T289A over TR34/L98H and TR53. All three resistance mechanisms were 
also genotypically different from strains with the same mutations from the Netherlands. This study is the first to 
demonstrate the highest frequency of this mutation in environmental strains in contrast to the formerly reported 
in Europe, Asia and Africa2,3,18,19. This work is also the first report of its association with soil of flower fields in 
South America. Since Colombia is the second exporter of cut flowers, we also analyzed whether dissemination 
could be possible from cut flowers but did not find any A. fumigatus on selected samples (unpublished data).
Although these mutations target an important biological function in the fungus, fitness cost has not been 
demonstrated for TR34/L98H and TR46/Y121F/T289A. Moreover, the presence of two or three genetic altera-
tions respectively could stabilize enzyme function compared with only one or two of these mutations20,21. Under 
selection pressure and prolonged exposure to fungicides, mutant strains could have greater resilience and may 
Figure 3. Structures of triazoles used in Colombian floriculture (A). Registration date of authorization for use 
in floriculture is provided after the name of the active product. (B) Clinical azole antifungal drugs with activity 
against aspergilli and to the right of the name the dates of clinical use authorization in Colombia. Source: 
National Center for Biotechnology Information. PubChem Compound Database; URL: https://pubchem.ncbi.
nlm.nih.govCID= 86132, https://pubchem.ncbi.nlm.nih.gov/compound/86132 (accessed Apr. 16, 2016).
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even predominate in the environment17. Finally, the impact of the TR53 mutation which has been found only 
once in clinical samples22, and once in the environment in Netherlands23 (data not published) has not yet been 
established, but considering its low frequency could have limitations on fungal adaptation to the environment. 
Although we only found two strains with this mutation not related to each other, in Colombia it could have 
achieved its adaptation to the environment.
The selection of TR46/Y121F/T289A alteration during long-term voriconazole therapy has been suggested 
recently24. However, in the absence of convincing proof it is now well accepted that these alterations are environ-
mental DMI fungicide-driven25. It is worth noting that a risk assessment of environmental resistance selection to 
DMIs during exposure in floriculture has been considered as a medium risk compared to veterinary and human 
use but a major risk in comparison to other agricultural practices7. Nevertheless, this exposure depends in part 
on the half-life of a fungicide that is conditioned by a number of factors including climate, soil composition, 
nature of the chemical, and number of fungicide applications. Because there are no specific growth seasons in 
tropical countries such as Colombia, the frequency of fungicide applications seems to be higher and could partly 
reflect the high consumption in this country. These frequent applications and the fact that triazole fungicides can 
persist a long time in soil26,27 could explain resistance development and the diversity of resistance mechanisms. 
Furthermore, it is unclear whether in real life conditions, fungicides utilized out of the established indications 
(different application frequency, too low doses, inappropriately used compounds according to the crops, etc.) 
could have facilitated TR46/Y121F/T289A predominance. Some limitations of this study reside in the lack of 
data regarding DMIs used in the studied flower fields and flowers beds, the frequency of use, the application 
procedures (bulb dipping, spraying or both) and possible rotations. Soil fungicide quantification was done in two 
representative pooled samples.
Our finding that two distinct sampling sites exhibited genotypically undistinguishable strains could be 
explained by clonal spread. Because resistance could also be induced in other crops in the same region where 
DMIs are used, we are currently conducting a study aimed at evaluating the presence of azole-resistant A. fumig-
atus related to potatoes, corn, carrots, beans, and other vegetables.
According to the Fungicide Resistance Action Committee (FRAC), among the possible mechanisms of gen-
eration of resistance in plant pathogenic fungi, all the models indicate that use of both fungicide mixtures and 
rotations can delay, but not prevent, emergence of resistant mutants8. It is also noted that in recent years fungicide 
consumption has decreased in Colombia but, and in parallel, has seen an increase in the consumption of fungi-
cide combinations11,15. It should be noted that with the exception of epoxiconazole (2009) and flutriafol (2006), 
all other fungicides have been marketed in Colombia since the early nineties while the medical azole antifungal 
drugs (itraconazole, voriconazole, posaconazole) were introduced to clinical use in (2000, 2004 and 2008 respec-
tively) the first decade of the 21st century (Fig. 3).
We also found a cyp51A wild-type strain with an azole-resistant phenotype, which is not surprising consider-
ing that multiple mechanisms of resistance have already been described such as increased drug efflux and a HapE 
mutation28,29.
Because prevalence of azole-resistant A. fumigatus is increasing around the world2,3,13, despite it has not been 
possible to demonstrate specifically the relationship between some fungicide triazoles and the emergence of 
resistance, is important to establish azole resistant control policies in different regions of the world. For the World 
Health Organization, it is a priority to delay antimicrobial resistance development and although current strategies 
are still focused on antibiotics, many of which could have a similar impact, not only on azole compounds used 
in agriculture, but also in human and animal health. It is likely that with the current information only restricting 
the use or stimulating the adherence to technical recommendations and establishing active surveillance of one or 
two fungicides and not a whole family would be enough. Indeed, this strategy has proved successful in the control 
of Extended-Spectrum Beta-Lactamases (ESBLs) in Enterobacteriaceae through the restriction of ceftazidime 
in favour of other beta-lactams instead30,31. Finally, restrictions of fungicides at an appropriate time could have 
the desired effect on preserving human antifungal therapy options in the future. In response to the emergence of 
human vancomycin resistant Enterococcus faecium (VRE), avoparcin, a vancomycin analogue used as an animal 
growth enhancer was discontinued leading to a decrease in the prevalence of VRE among farm animals32.
Albeit the study findings cannot be generalized to all the Colombian floriculture and much less to the overall 
situation of the country, they suggest that azole-resistant A. fumigatus is at the present time becoming a potential 
public health issue. Indeed, until recently, the only region in the world which had not reported the presence of 
resistance was Latin America. Now it is necessary to evaluate the true prevalence in this region and what the 
real impact is on human health. In this regard, it is important to realize that all TR46/Y121F/T289A strains are 
resistant to voriconazole, the first-line treatment for patients with invasive aspergillosis16,18,33. In addition, azole 
resistant A. fumigatus harbouring TR46/Y121F/T289A are also resistant to isavuconazole, the new medical anti-
fungal compound which is considered a good therapeutic option for aspergillosis34. Currently we are evaluating 
the incidence of A. fumigatus on exacerbations during chronic obstructive pulmonary disease in the same region.
In conclusion, our study showed evidence of a larger geographical spread of azole resistance in A. fumigatus 
now also in Latin America. These findings also highlight the great diversity in molecular resistance mechanisms 
and the predominance of TR46/Y121F/T289A strains associated with high-level resistance to voriconazole, a 
first-line treatment for patients with invasive aspergillosis. Finally, these data underline the need for targeted 
investigations to determine the prevalence of azole resistance in A. fumigatus in both clinical and environmental 
samples in other regions of Colombia and Latin America.
Methods
Study Design. To recover A. fumigatus strains from the outdoor environment, 2 g of each soil sample was 
suspended in 0.85% NaCl plus 0.01% Tween20, vortexed and allowed to settle, as described previously4. From 
the supernatant, 50 μ l was plated on Sabouraud dextrose agar (SDA) and incubated at 43 °C for 48 hours to select 
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Aspergillus fumigatus. Aspergillus section Fumigati identification was obtained by both macroscopic and micro-
scopic characteristics.
Azole Resistance Detection. To detect azole-resistant A. fumigatus, conidia were suspended in 0.85% NaCl 
plus 0.01% Tween20 at a 0.5 McFarland turbidity and 50 μ l of inoculum suspensions were added on Sabouraud 
agar plates containing 4 mg/L of either itraconazole or voriconazole (both Sigma–Aldrich, Saint-Quentin 
Fallavier, France) and they were then incubated at 37 °C for 48 h35. Up to 5 colonies for each positive culture were 
selected and genomic DNA was extracted from the azole-resistant strains using the NucleoSpin® Microbial DNA 
procedure (Macherey-Nagel GmbH & Co., Düren, Germany) according to the manufacturer’s instructions.
Mutation Analysis. Azole-resistant A. fumigatus sensu stricto strains were identified by amplification and 
sequencing of a portion of the β -tubulin gene36. To study the resistance mechanism involved in these strains, 
the cyp51A gene and a 234 bp region of its promoter were further analyzed by sequencing as described previ-
ously37. Nucleotide sequences were compared with the reference sequence of the A. fumigatus azole-susceptible 
strain CM-237 (GenBank accession number AF338659) using Seqscape (Applied Biosystems, Foster City, CA) 
for cyp51A gene and ClustalW analysis by means of BioEdit® software version 7.1.11.0 (Carlsbad, CA) for the 
promoter region.
Microsatellite Typing. Genotyping was performed on all A. fumigatus strains able to grow on 4 mg/L 
itraconazole or voriconazole, using microsatellite typing, as described previously38. The fragment sizes were 
determined by addition of the CC-ROX500 marker and subsequent analysis of the fragments on the Applied 
Biosystems ABI3500xL Genetic Analyzer. Assignment of repeat numbers for each of the nine markers was deter-
mined by using the GeneMapper package version 1.0 software (Applied Biosystems). Repeat numbers of these 
strains were compared to a collection of Dutch TR46/Y121F/T289A (n = 12), TR34/L98H (n = 14) and TR53 (n = 1) 
positive strains. Allele sharing distance matrices were generated from the tandem repeat numbers and were used 
as input to the Neighbor program of the PHYLIP version 3.6 software package to produce dendrograms.
Fungicide detection. Soil samples were examined for the following azole fungicides: azaconazole, cypro-
conazole, difenoconazole, epoxyconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, penconazole, 
propiconazole, tebuconazole, tetraconazole and triadimenole using liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) with a limit of quantification (LOQ) of 0.05 mg/kg39. Briefly, dried, finely homogenized 
soil samples (10 g) were extracted by the Dionex ASE 200 system (Thermo Fisher Scientific, France) using metha-
nol/dichloromethane (85:15, v/v) as solvent. Extracts were evaporated under a stream of nitrogen before the solid 
phase extraction (SPE) using Oasis® MAX (6 mL, 150 mg) from Waters (Guyancourt, France). The cartridges 
were conditioned with 6 mL dichloromethane and then 6 mL of methanol and the elution was performed with 
two volumes of 5 mL, firstly 100% methanol and then dichloromethane. After evaporation under a stream of 
nitrogen, internal standard fungicide was added and the mixture evaporated to dryness. Following the analytical 
protocol, the sample extract was reconstituted in 500 μ l of water:acetonitrile (90:10, v/v). High performance liquid 
chromatography (HPLC) was performed with a Gemini-NX C18 3 μ m, 100 mm × 2 mm with a SecurityGuard 
cartridge Gemini-NX C18 3 μ m, 4 mm × 2.0 mm, both from Phenomenex (Le Pecq, France). Acetonitrile and 
5 mM ammonium acetate solution were used with an analytical gradient of 15 min. The detector was a API 2000 
triple quadrupole (Applied Biosystems/MDS/SCIEX, Villebon sur Yvette, France) mass spectrometer equipped 
with an electrospray ionization source (ESI) that was operated in the positive ionization mode. Mass acquisition 
was performed in the sSRM mode. Analyst software 1.5.2 was used with the SRM algorithm for acquiring and 
interpreting the results.
Antifungal Susceptibility Testing. Antifungal activity (MIC) of flutriafol used in Colombian floriculture 
was investigated against wild-type and azole-resistant strains using the European Committee for Antimicrobial 
Susceptibility Testing (EUCAST) standard method for moulds40. Tebuconazole was used as comparator.
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